Baixinan (2185.HK): Medtronic RDN products have been approved in the US and it is expected that the domestic commercialization process will soon begin
德邦證券Nov 23, 2023 18:16
Baishinan (2185.HK), a domestic RDN pioneer, is expected to be approved for release in 24
德邦證券Aug 19, 2023 00:00
Baixinan-B (2185.HK): IPO Purchase Guide
國元國際Nov 16, 2021 00:00
No Data
No Data